Literature DB >> 12244309

A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Heather L E Lang1, Helle Jacobsen, Shinji Ikemizu, Christina Andersson, Karl Harlos, Lars Madsen, Peter Hjorth, Leif Sondergaard, Arne Svejgaard, Kai Wucherpfennig, David I Stuart, John I Bell, E Yvonne Jones, Lars Fugger.   

Abstract

The multiple sclerosis (MS)-associated HLA major histocompatibility complex (MHC) class II alleles DRB1*1501, DRB5*0101 and DQB1*0602 are in strong linkage disequilibrium, making it difficult to determine which is the principal MS risk gene. Here we show that together the DRB1 and DRB5 loci may influence susceptibility to MS. We demonstrate that a T cell receptor (TCR) from an MS patient recognized both a DRB1*1501-restricted myelin basic protein (MBP) and DRB5*0101-restricted Epstein-Barr virus (EBV) peptide. Crystal structure determination of the DRB5*0101-EBV peptide complex revealed a marked degree of structural equivalence to the DRB1*1501-MBP peptide complex at the surface presented for TCR recognition. This provides structural evidence for molecular mimicry involving HLA molecules. The structural details suggest an explanation for the preponderance of MHC class II associations in HLA-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244309     DOI: 10.1038/ni835

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  163 in total

Review 1.  Development of anti-CD20 therapy for multiple sclerosis.

Authors:  Beatrix Bartok; Gregg J Silverman
Journal:  Exp Cell Res       Date:  2011-04-12       Impact factor: 3.905

Review 2.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

3.  Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells.

Authors:  Trygve Holmøy; Frode Vartdal
Journal:  J Neurovirol       Date:  2004-02       Impact factor: 2.643

4.  Autoimmunity's next top models.

Authors:  Hartmut Wekerle; Alexander Flügel; Lars Fugger; Georg Schett; David Serreze
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

Review 5.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.

Authors:  A Ascherio; K L Munger
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 6.  Leprosy as a genetic disease.

Authors:  Andrea Alter; Audrey Grant; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  Mamm Genome       Date:  2010-10-09       Impact factor: 2.957

7.  Molecular mimicry revisited: gut bacteria and multiple sclerosis.

Authors:  Fred C Westall
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 8.  [Multiple sclerosis and Epstein-Barr virus : new developments and perspectives].

Authors:  K Ruprecht
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

9.  Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice.

Authors:  Marwa Shehab; Nour Sherri; Hadi Hussein; Noor Salloum; Elias A Rahal
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

10.  Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.

Authors:  Yili Li; Yuping Huang; Jessica Lue; Jacqueline A Quandt; Roland Martin; Roy A Mariuzza
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.